data_2mma_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mma _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 pp . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -104.24 166.13 12.16 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.38 -32.01 92.72 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 N-CA-C 116.565 1.717 . . . . 0.0 116.565 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -65.3 -43.77 90.02 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.907 1.23 . . . . 0.0 111.252 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.93 -38.7 91.82 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -62.42 -42.71 99.65 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.998 -0.438 . . . . 0.0 110.784 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.76 -40.6 95.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.214 0.531 . . . . 0.0 111.176 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.5 m -64.38 -43.3 94.92 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.114 -0.366 . . . . 0.0 110.967 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.05 -38.63 91.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.534 0.606 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -61.4 -42.93 99.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.946 0.403 . . . . 0.0 111.339 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -68.14 -41.53 81.48 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.935 -0.478 . . . . 0.0 110.774 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.3 tp -63.29 -43.49 97.74 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.29 0.636 . . . . 0.0 112.456 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.8 m -73.73 -19.94 17.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 121.432 -0.793 . . . . 0.0 111.703 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -93.4 -6.99 45.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 96.6 p -65.87 -27.46 68.24 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -138.83 153.62 48.38 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -65.91 -27.94 68.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.518 0.599 . . . . 0.0 111.505 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.86 126.05 56.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 174.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.6 t -127.09 130.02 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 tp -118.69 107.27 13.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.928 0.871 . . . . 0.0 110.297 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -89.65 122.94 33.26 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 24.8 ptm -149.2 168.79 22.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.706 0.765 . . . . 0.0 112.715 -165.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -86.85 103.5 15.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.51 -161.38 16.1 Favored Glycine 0 N--CA 1.455 -0.099 0 N-CA-C 113.732 0.253 . . . . 0.0 113.732 -177.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.4 p -117.36 168.01 10.74 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -62.92 -33.33 75.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 118.821 0.737 . . . . 0.0 112.297 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -76.87 -33.13 57.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 119.563 1.074 . . . . 0.0 111.153 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.84 73.5 78.79 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.01 146.16 70.14 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.067 -2.155 . . . . 0.0 109.864 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 93.7 mmm -105.25 4.92 31.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -173.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -153.73 143.86 22.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.82 -36.99 94.12 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.845 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -63.35 -35.69 81.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.308 1.554 . . . . 0.0 111.608 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 63.2 m -69.2 -40.32 78.1 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.911 -0.493 . . . . 0.0 110.079 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -64.18 -36.99 85.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.2 m -59.76 -44.13 94.0 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.9 t -69.23 -40.46 80.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.393 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.5 t -61.68 -44.65 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -63.01 -36.79 84.75 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.354 -0.841 . . . . 0.0 111.924 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.0 -43.95 98.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.717 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.73 -26.03 65.05 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.148 -0.97 . . . . 0.0 111.399 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -77.56 -33.96 53.86 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.151 -0.968 . . . . 0.0 112.556 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -62.53 -41.03 98.59 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.872 0.844 . . . . 0.0 109.271 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.22 0.27 56.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.436 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.2 t30 52.45 47.41 24.77 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.955 1.302 . . . . 0.0 113.739 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -90.5 123.4 65.45 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.135 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.37 140.99 31.16 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 113.971 -3.553 . . . . 0.0 109.211 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -154.59 162.67 41.03 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 120.879 -1.138 . . . . 0.0 112.203 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -100.65 124.61 46.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -100.72 135.17 42.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.25 125.23 61.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -88.79 101.1 13.68 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -78.47 -6.79 9.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.9 mt -71.49 -21.0 62.0 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.329 -0.857 . . . . 0.0 110.53 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -108.25 11.48 27.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.968 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -144.76 92.96 2.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.436 0.636 . . . . 0.0 111.679 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.08 -37.94 89.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.4 tpp -68.37 -38.79 81.75 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.274 -0.891 . . . . 0.0 110.555 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.7 tp -64.06 -44.87 91.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -58.4 -47.02 85.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.525 0.679 . . . . 0.0 111.195 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -72.75 -35.51 67.5 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.73 -44.04 82.32 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.1 -37.87 88.92 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.037 -0.684 . . . . 0.0 112.592 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -54.79 -37.79 66.49 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.554 0.161 . . . . 0.0 111.407 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -86.07 -36.21 19.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.376 0.608 . . . . 0.0 111.19 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.68 -47.91 79.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.288 0.566 . . . . 0.0 111.738 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 71.3 p -81.08 -14.43 57.79 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.864 -0.523 . . . . 0.0 112.313 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 30.4 m120 53.61 40.46 31.46 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.502 0.721 . . . . 0.0 110.208 -167.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -134.97 97.99 13.34 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -69.9 -6.5 18.82 Favored 'Trans proline' 0 C--O 1.238 0.492 0 N-CA-C 121.308 3.541 . . . . 0.0 121.308 -169.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.7 p -112.55 165.21 12.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.852 0.751 . . . . 0.0 110.407 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.21 150.81 60.94 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.38 157.17 88.05 Favored 'Cis proline' 0 C--N 1.345 0.392 0 N-CA-C 117.767 2.18 . . . . 0.0 117.767 4.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -126.03 123.17 37.85 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.7 tp -107.79 130.25 54.98 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -118.8 137.58 53.3 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 77.7 mt -136.75 130.04 45.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.34 25.6 75.32 Favored Glycine 0 C--O 1.235 0.174 0 O-C-N 122.117 -0.364 . . . . 0.0 112.467 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 79.95 5.77 89.39 Favored Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 114.481 0.552 . . . . 0.0 114.481 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -124.83 145.92 49.53 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -66.57 121.56 15.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -89.77 -48.03 7.52 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 169.85 175.86 39.16 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 118.999 -1.572 . . . . 0.0 116.236 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -93.17 -164.9 37.71 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 31.6 t -62.4 -42.0 99.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 118.01 0.905 . . . . 0.0 112.851 -173.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -68.5 -38.84 81.32 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.261 -0.899 . . . . 0.0 113.094 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.32 -44.73 94.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 58.9 m -63.11 -40.11 96.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 45.9 tp -66.4 -43.58 85.39 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.758 -0.588 . . . . 0.0 110.562 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -69.02 -32.9 72.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.709 0.766 . . . . 0.0 109.739 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.55 -35.46 79.09 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.219 -0.926 . . . . 0.0 111.749 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -67.96 -40.39 83.2 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.163 -0.961 . . . . 0.0 109.892 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.63 -20.1 64.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.8 p -106.81 -10.23 16.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 88.33 -6.95 82.96 Favored Glycine 0 C--O 1.226 -0.383 0 O-C-N 121.645 -0.659 . . . . 0.0 113.352 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -68.34 -25.0 64.88 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.687 -0.89 . . . . 0.0 113.081 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.29 -42.93 64.95 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -63.23 -38.4 91.01 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -61.39 -39.67 91.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 118.396 0.544 . . . . 0.0 112.015 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -73.7 -38.22 64.93 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.025 -0.422 . . . . 0.0 112.121 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.72 -42.94 96.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.11 -42.86 99.29 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -58.74 -47.76 83.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.97 -46.23 78.81 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.85 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 95.7 mmm -66.15 -33.15 75.13 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 121.903 -0.498 . . . . 0.0 111.647 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 77.4 m -84.05 -13.81 52.19 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.838 -0.601 . . . . 0.0 109.651 177.634 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 71.8 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 50.3 p -127.08 165.02 20.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 171.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.14 -39.57 75.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.218 0.532 . . . . 0.0 110.4 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -65.89 -32.79 74.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.441 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -73.34 -38.57 65.71 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.309 -0.869 . . . . 0.0 110.14 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 57.1 t -60.62 -47.74 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -62.66 -46.19 89.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.407 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.03 -41.1 87.15 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 17.3 p -67.05 -38.08 85.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.171 0.51 . . . . 0.0 110.808 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.7 -38.12 73.62 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.213 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -65.15 -46.67 79.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 25.8 p -65.06 -32.38 74.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.409 0.623 . . . . 0.0 111.11 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -83.79 -54.38 4.94 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 64.9 mt -89.75 -11.1 43.23 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -165.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 49.58 53.53 14.51 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 123.623 0.769 . . . . 0.0 112.379 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.58 146.39 38.91 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 116.975 -1.55 . . . . 0.0 115.048 -168.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -82.99 -31.23 8.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -143.71 139.37 29.45 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 169.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 52.5 tp -135.11 140.71 45.68 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 172.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -128.41 135.46 49.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 167.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 88.1 t -127.62 131.9 69.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 102.771 -3.048 . . . . 0.0 102.771 171.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 64.1 mt -124.53 122.42 63.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -76.36 120.44 21.61 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 27.5 pt -107.96 2.83 9.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 122.184 0.993 . . . . 0.0 111.279 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 88.5 p -90.15 7.52 37.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.328 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.0 22.99 53.87 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.271 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.22 10.14 78.49 Favored Glycine 0 C--N 1.325 -0.072 0 O-C-N 121.993 -0.71 . . . . 0.0 112.485 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' CYS . . . . . . . . . . . . . 47.6 t -74.71 -16.62 60.74 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.11 -0.641 . . . . 0.0 110.825 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.88 21.93 77.72 Favored Glycine 0 N--CA 1.454 -0.133 0 O-C-N 121.363 -0.836 . . . . 0.0 111.711 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 79.2 p -113.01 -17.58 12.41 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.5 m -144.15 138.44 28.15 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.194 0.907 . . . . 0.0 110.442 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -137.27 155.67 49.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -116.87 141.15 48.59 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 166.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 95.1 t -135.99 134.29 50.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.765 0.426 . . . . 0.0 111.052 -173.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -124.2 129.39 50.72 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 171.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 t -125.78 142.99 40.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.07 128.8 70.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 169.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 42.0 t -157.76 150.78 23.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 119.436 1.016 . . . . 0.0 109.235 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -75.65 -13.35 60.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.995 -0.441 . . . . 0.0 110.237 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -63.98 -22.52 66.96 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.974 -0.454 . . . . 0.0 111.094 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -79.74 -11.39 59.84 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.36 138.95 55.8 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.09 4.14 84.5 Favored Glycine 0 C--O 1.237 0.284 0 CA-C-O 121.595 0.553 . . . . 0.0 113.422 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -125.67 134.01 51.98 Favored 'General case' 0 CA--C 1.51 -0.576 0 O-C-N 122.09 -0.653 . . . . 0.0 109.706 -173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 29.9 mmt85 -77.08 158.33 30.55 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 22.0 tp -56.32 -33.54 65.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -170.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.41 -42.65 99.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.699 0.761 . . . . 0.0 110.833 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -66.5 -37.46 85.12 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.124 -0.985 . . . . 0.0 110.006 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -66.5 -40.11 89.08 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.889 -0.507 . . . . 0.0 111.637 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -62.58 -41.86 99.2 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -59.48 -37.72 78.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.476 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' MET . . . . . . . . . . . . . 59.1 mtp -63.46 -41.77 98.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.597 0.635 . . . . 0.0 111.829 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -68.72 -43.35 83.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -63.7 -36.31 83.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.75 -32.6 72.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.116 0.484 . . . . 0.0 110.224 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.66 -43.11 81.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.06 35.26 2.26 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.551 1.167 . . . . 0.0 112.433 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -58.77 -34.99 72.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 -36.09 65.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.955 0.883 . . . . 0.0 111.994 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.68 -37.24 73.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.188 0.994 . . . . 0.0 110.027 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 47.6 tpp -58.64 -26.7 64.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.772 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -71.19 -17.39 62.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.007 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -115.98 -38.93 3.54 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 45.4 pt -66.03 156.11 6.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -103.24 -11.57 17.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.958 -1.474 . . . . 0.0 114.043 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.19 152.44 20.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 119.021 0.828 . . . . 0.0 111.449 166.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.4 tp -143.44 132.23 22.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.67 94.2 3.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.854 0.835 . . . . 0.0 109.744 172.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -73.26 119.43 20.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -100.32 -37.89 8.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -139.81 143.4 36.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.96 55.42 1.31 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -88.05 151.17 22.94 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -160.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 70.9 p -72.57 159.91 84.16 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 162.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.25 -29.19 88.42 Favored 'Trans proline' 0 N--CA 1.473 0.269 0 C-N-CA 116.803 -1.665 . . . . 0.0 113.766 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -70.19 -30.55 67.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -76.04 -37.41 58.36 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.023 -1.048 . . . . 0.0 111.091 172.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -63.14 -42.03 99.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.084 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -127.09 86.87 57.87 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 118.333 -0.645 . . . . 0.0 112.967 -178.96 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 pp . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -104.24 166.13 12.16 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.38 -32.01 92.72 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 N-CA-C 116.565 1.717 . . . . 0.0 116.565 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -65.3 -43.77 90.02 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.907 1.23 . . . . 0.0 111.252 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.93 -38.7 91.82 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -62.42 -42.71 99.65 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.998 -0.438 . . . . 0.0 110.784 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.76 -40.6 95.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.214 0.531 . . . . 0.0 111.176 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.5 m -64.38 -43.3 94.92 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.114 -0.366 . . . . 0.0 110.967 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.05 -38.63 91.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.534 0.606 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -61.4 -42.93 99.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.946 0.403 . . . . 0.0 111.339 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -68.14 -41.53 81.48 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.935 -0.478 . . . . 0.0 110.774 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.3 tp -63.29 -43.49 97.74 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.29 0.636 . . . . 0.0 112.456 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.8 m -73.73 -19.94 17.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 121.432 -0.793 . . . . 0.0 111.703 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -93.4 -6.99 45.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 96.6 p -65.87 -27.46 68.24 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -138.83 153.62 48.38 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -65.91 -27.94 68.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.518 0.599 . . . . 0.0 111.505 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.86 126.05 56.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 174.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.6 t -127.09 130.02 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 tp -118.69 107.27 13.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.928 0.871 . . . . 0.0 110.297 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -89.65 122.94 33.26 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 24.8 ptm -149.2 168.79 22.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.706 0.765 . . . . 0.0 112.715 -165.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -86.85 103.5 15.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.51 -161.38 16.1 Favored Glycine 0 N--CA 1.455 -0.099 0 N-CA-C 113.732 0.253 . . . . 0.0 113.732 -177.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.4 p -117.36 168.01 10.74 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -62.92 -33.33 75.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 118.821 0.737 . . . . 0.0 112.297 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -76.87 -33.13 57.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 119.563 1.074 . . . . 0.0 111.153 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.84 73.5 78.79 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.01 146.16 70.14 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.067 -2.155 . . . . 0.0 109.864 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 93.7 mmm -105.25 4.92 31.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -173.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -153.73 143.86 22.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.82 -36.99 94.12 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.845 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -63.35 -35.69 81.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.308 1.554 . . . . 0.0 111.608 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 63.2 m -69.2 -40.32 78.1 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.911 -0.493 . . . . 0.0 110.079 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -64.18 -36.99 85.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.2 m -59.76 -44.13 94.0 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.41 HG13 HG21 ' A' ' 154' ' ' THR . 64.9 t -69.23 -40.46 80.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.393 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.5 t -61.68 -44.65 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -63.01 -36.79 84.75 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.354 -0.841 . . . . 0.0 111.924 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.0 -43.95 98.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.717 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.73 -26.03 65.05 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.148 -0.97 . . . . 0.0 111.399 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -77.56 -33.96 53.86 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.151 -0.968 . . . . 0.0 112.556 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -62.53 -41.03 98.59 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.872 0.844 . . . . 0.0 109.271 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.22 0.27 56.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.436 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.2 t30 52.45 47.41 24.77 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.955 1.302 . . . . 0.0 113.739 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -90.5 123.4 65.45 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.135 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.37 140.99 31.16 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 113.971 -3.553 . . . . 0.0 109.211 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -154.59 162.67 41.03 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 120.879 -1.138 . . . . 0.0 112.203 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -100.65 124.61 46.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -100.72 135.17 42.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.25 125.23 61.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -88.79 101.1 13.68 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -78.47 -6.79 9.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.9 mt -71.49 -21.0 62.0 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.329 -0.857 . . . . 0.0 110.53 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -108.25 11.48 27.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.968 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -144.76 92.96 2.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.436 0.636 . . . . 0.0 111.679 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.08 -37.94 89.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.4 tpp -68.37 -38.79 81.75 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.274 -0.891 . . . . 0.0 110.555 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.7 tp -64.06 -44.87 91.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -58.4 -47.02 85.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.525 0.679 . . . . 0.0 111.195 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -72.75 -35.51 67.5 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.73 -44.04 82.32 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.1 -37.87 88.92 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.037 -0.684 . . . . 0.0 112.592 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -54.79 -37.79 66.49 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.554 0.161 . . . . 0.0 111.407 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -86.07 -36.21 19.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.376 0.608 . . . . 0.0 111.19 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.68 -47.91 79.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.288 0.566 . . . . 0.0 111.738 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 71.3 p -81.08 -14.43 57.79 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.864 -0.523 . . . . 0.0 112.313 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 30.4 m120 53.61 40.46 31.46 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.502 0.721 . . . . 0.0 110.208 -167.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -134.97 97.99 13.34 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -69.9 -6.5 18.82 Favored 'Trans proline' 0 C--O 1.238 0.492 0 N-CA-C 121.308 3.541 . . . . 0.0 121.308 -169.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.7 p -112.55 165.21 12.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.852 0.751 . . . . 0.0 110.407 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.21 150.81 60.94 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.38 157.17 88.05 Favored 'Cis proline' 0 C--N 1.345 0.392 0 N-CA-C 117.767 2.18 . . . . 0.0 117.767 4.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -126.03 123.17 37.85 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.7 tp -107.79 130.25 54.98 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -118.8 137.58 53.3 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 77.7 mt -136.75 130.04 45.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.34 25.6 75.32 Favored Glycine 0 C--O 1.235 0.174 0 O-C-N 122.117 -0.364 . . . . 0.0 112.467 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 79.95 5.77 89.39 Favored Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 114.481 0.552 . . . . 0.0 114.481 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -124.83 145.92 49.53 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -66.57 121.56 15.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -89.77 -48.03 7.52 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 169.85 175.86 39.16 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 118.999 -1.572 . . . . 0.0 116.236 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -93.17 -164.9 37.71 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 31.6 t -62.4 -42.0 99.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 118.01 0.905 . . . . 0.0 112.851 -173.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -68.5 -38.84 81.32 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.261 -0.899 . . . . 0.0 113.094 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.32 -44.73 94.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.41 HG21 HG13 ' A' ' 103' ' ' VAL . 58.9 m -63.11 -40.11 96.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 45.9 tp -66.4 -43.58 85.39 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.758 -0.588 . . . . 0.0 110.562 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -69.02 -32.9 72.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.709 0.766 . . . . 0.0 109.739 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.55 -35.46 79.09 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.219 -0.926 . . . . 0.0 111.749 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -67.96 -40.39 83.2 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.163 -0.961 . . . . 0.0 109.892 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.63 -20.1 64.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.8 p -106.81 -10.23 16.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 88.33 -6.95 82.96 Favored Glycine 0 C--O 1.226 -0.383 0 O-C-N 121.645 -0.659 . . . . 0.0 113.352 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -68.34 -25.0 64.88 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.687 -0.89 . . . . 0.0 113.081 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.29 -42.93 64.95 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -63.23 -38.4 91.01 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -61.39 -39.67 91.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 118.396 0.544 . . . . 0.0 112.015 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -73.7 -38.22 64.93 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.025 -0.422 . . . . 0.0 112.121 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.72 -42.94 96.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.11 -42.86 99.29 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -58.74 -47.76 83.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.97 -46.23 78.81 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.85 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 95.7 mmm -66.15 -33.15 75.13 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 121.903 -0.498 . . . . 0.0 111.647 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 77.4 m -84.05 -13.81 52.19 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.838 -0.601 . . . . 0.0 109.651 177.634 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 71.8 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 50.3 p -127.08 165.02 20.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 171.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.14 -39.57 75.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.218 0.532 . . . . 0.0 110.4 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -65.89 -32.79 74.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.441 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -73.34 -38.57 65.71 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.309 -0.869 . . . . 0.0 110.14 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 57.1 t -60.62 -47.74 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -62.66 -46.19 89.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.407 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.03 -41.1 87.15 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 17.3 p -67.05 -38.08 85.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.171 0.51 . . . . 0.0 110.808 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.7 -38.12 73.62 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.213 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -65.15 -46.67 79.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 25.8 p -65.06 -32.38 74.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.409 0.623 . . . . 0.0 111.11 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -83.79 -54.38 4.94 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 64.9 mt -89.75 -11.1 43.23 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -165.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 49.58 53.53 14.51 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 123.623 0.769 . . . . 0.0 112.379 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.58 146.39 38.91 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 116.975 -1.55 . . . . 0.0 115.048 -168.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -82.99 -31.23 8.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -143.71 139.37 29.45 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 169.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 52.5 tp -135.11 140.71 45.68 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 172.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -128.41 135.46 49.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 167.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 88.1 t -127.62 131.9 69.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 102.771 -3.048 . . . . 0.0 102.771 171.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 64.1 mt -124.53 122.42 63.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -76.36 120.44 21.61 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 27.5 pt -107.96 2.83 9.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 122.184 0.993 . . . . 0.0 111.279 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 88.5 p -90.15 7.52 37.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.328 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.0 22.99 53.87 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.271 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.22 10.14 78.49 Favored Glycine 0 C--N 1.325 -0.072 0 O-C-N 121.993 -0.71 . . . . 0.0 112.485 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' CYS . . . . . . . . . . . . . 47.6 t -74.71 -16.62 60.74 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.11 -0.641 . . . . 0.0 110.825 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.88 21.93 77.72 Favored Glycine 0 N--CA 1.454 -0.133 0 O-C-N 121.363 -0.836 . . . . 0.0 111.711 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 79.2 p -113.01 -17.58 12.41 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.5 m -144.15 138.44 28.15 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.194 0.907 . . . . 0.0 110.442 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -137.27 155.67 49.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -116.87 141.15 48.59 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 166.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 95.1 t -135.99 134.29 50.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.765 0.426 . . . . 0.0 111.052 -173.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -124.2 129.39 50.72 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 171.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 t -125.78 142.99 40.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.07 128.8 70.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 169.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 42.0 t -157.76 150.78 23.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 119.436 1.016 . . . . 0.0 109.235 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -75.65 -13.35 60.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.995 -0.441 . . . . 0.0 110.237 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -63.98 -22.52 66.96 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.974 -0.454 . . . . 0.0 111.094 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -79.74 -11.39 59.84 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.36 138.95 55.8 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.09 4.14 84.5 Favored Glycine 0 C--O 1.237 0.284 0 CA-C-O 121.595 0.553 . . . . 0.0 113.422 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -125.67 134.01 51.98 Favored 'General case' 0 CA--C 1.51 -0.576 0 O-C-N 122.09 -0.653 . . . . 0.0 109.706 -173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 29.9 mmt85 -77.08 158.33 30.55 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 22.0 tp -56.32 -33.54 65.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -170.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.41 -42.65 99.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.699 0.761 . . . . 0.0 110.833 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -66.5 -37.46 85.12 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.124 -0.985 . . . . 0.0 110.006 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -66.5 -40.11 89.08 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.889 -0.507 . . . . 0.0 111.637 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -62.58 -41.86 99.2 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -59.48 -37.72 78.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.476 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' MET . . . . . . . . . . . . . 59.1 mtp -63.46 -41.77 98.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.597 0.635 . . . . 0.0 111.829 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -68.72 -43.35 83.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -63.7 -36.31 83.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.75 -32.6 72.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.116 0.484 . . . . 0.0 110.224 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.66 -43.11 81.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.06 35.26 2.26 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.551 1.167 . . . . 0.0 112.433 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -58.77 -34.99 72.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 -36.09 65.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.955 0.883 . . . . 0.0 111.994 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.68 -37.24 73.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.188 0.994 . . . . 0.0 110.027 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 47.6 tpp -58.64 -26.7 64.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.772 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -71.19 -17.39 62.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.007 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -115.98 -38.93 3.54 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 45.4 pt -66.03 156.11 6.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -103.24 -11.57 17.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.958 -1.474 . . . . 0.0 114.043 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.19 152.44 20.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 119.021 0.828 . . . . 0.0 111.449 166.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.4 tp -143.44 132.23 22.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.67 94.2 3.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.854 0.835 . . . . 0.0 109.744 172.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -73.26 119.43 20.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -100.32 -37.89 8.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -139.81 143.4 36.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.96 55.42 1.31 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -88.05 151.17 22.94 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -160.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 70.9 p -72.57 159.91 84.16 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 162.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.25 -29.19 88.42 Favored 'Trans proline' 0 N--CA 1.473 0.269 0 C-N-CA 116.803 -1.665 . . . . 0.0 113.766 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -70.19 -30.55 67.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -76.04 -37.41 58.36 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.023 -1.048 . . . . 0.0 111.091 172.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -63.14 -42.03 99.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.084 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -127.09 86.87 57.87 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 118.333 -0.645 . . . . 0.0 112.967 -178.96 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 pp . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -104.24 166.13 12.16 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.38 -32.01 92.72 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 N-CA-C 116.565 1.717 . . . . 0.0 116.565 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -65.3 -43.77 90.02 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.907 1.23 . . . . 0.0 111.252 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.93 -38.7 91.82 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -62.42 -42.71 99.65 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.998 -0.438 . . . . 0.0 110.784 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.76 -40.6 95.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.214 0.531 . . . . 0.0 111.176 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.5 m -64.38 -43.3 94.92 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.114 -0.366 . . . . 0.0 110.967 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.05 -38.63 91.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.534 0.606 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -61.4 -42.93 99.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.946 0.403 . . . . 0.0 111.339 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -68.14 -41.53 81.48 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.935 -0.478 . . . . 0.0 110.774 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.3 tp -63.29 -43.49 97.74 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.29 0.636 . . . . 0.0 112.456 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.8 m -73.73 -19.94 17.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 121.432 -0.793 . . . . 0.0 111.703 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -93.4 -6.99 45.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 96.6 p -65.87 -27.46 68.24 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -138.83 153.62 48.38 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -65.91 -27.94 68.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.518 0.599 . . . . 0.0 111.505 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.86 126.05 56.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 174.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.6 t -127.09 130.02 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 tp -118.69 107.27 13.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.928 0.871 . . . . 0.0 110.297 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -89.65 122.94 33.26 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 24.8 ptm -149.2 168.79 22.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.706 0.765 . . . . 0.0 112.715 -165.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -86.85 103.5 15.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.51 -161.38 16.1 Favored Glycine 0 N--CA 1.455 -0.099 0 N-CA-C 113.732 0.253 . . . . 0.0 113.732 -177.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.4 p -117.36 168.01 10.74 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -62.92 -33.33 75.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 118.821 0.737 . . . . 0.0 112.297 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -76.87 -33.13 57.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 119.563 1.074 . . . . 0.0 111.153 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.84 73.5 78.79 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.01 146.16 70.14 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.067 -2.155 . . . . 0.0 109.864 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 93.7 mmm -105.25 4.92 31.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -173.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -153.73 143.86 22.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.82 -36.99 94.12 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.845 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -63.35 -35.69 81.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.308 1.554 . . . . 0.0 111.608 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 63.2 m -69.2 -40.32 78.1 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.911 -0.493 . . . . 0.0 110.079 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -64.18 -36.99 85.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.2 m -59.76 -44.13 94.0 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.41 HG13 HG21 ' A' ' 154' ' ' THR . 64.9 t -69.23 -40.46 80.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.393 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.5 t -61.68 -44.65 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -63.01 -36.79 84.75 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.354 -0.841 . . . . 0.0 111.924 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.0 -43.95 98.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.717 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.73 -26.03 65.05 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.148 -0.97 . . . . 0.0 111.399 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -77.56 -33.96 53.86 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.151 -0.968 . . . . 0.0 112.556 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -62.53 -41.03 98.59 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.872 0.844 . . . . 0.0 109.271 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.22 0.27 56.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.436 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.2 t30 52.45 47.41 24.77 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.955 1.302 . . . . 0.0 113.739 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -90.5 123.4 65.45 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.135 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.37 140.99 31.16 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 113.971 -3.553 . . . . 0.0 109.211 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -154.59 162.67 41.03 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 120.879 -1.138 . . . . 0.0 112.203 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -100.65 124.61 46.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -100.72 135.17 42.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.25 125.23 61.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -88.79 101.1 13.68 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -78.47 -6.79 9.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.9 mt -71.49 -21.0 62.0 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.329 -0.857 . . . . 0.0 110.53 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -108.25 11.48 27.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.968 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -144.76 92.96 2.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.436 0.636 . . . . 0.0 111.679 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.08 -37.94 89.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.4 tpp -68.37 -38.79 81.75 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.274 -0.891 . . . . 0.0 110.555 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.7 tp -64.06 -44.87 91.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -58.4 -47.02 85.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.525 0.679 . . . . 0.0 111.195 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -72.75 -35.51 67.5 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.73 -44.04 82.32 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.1 -37.87 88.92 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.037 -0.684 . . . . 0.0 112.592 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -54.79 -37.79 66.49 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.554 0.161 . . . . 0.0 111.407 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -86.07 -36.21 19.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.376 0.608 . . . . 0.0 111.19 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -63.68 -47.91 79.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.288 0.566 . . . . 0.0 111.738 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 71.3 p -81.08 -14.43 57.79 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.864 -0.523 . . . . 0.0 112.313 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 30.4 m120 53.61 40.46 31.46 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.502 0.721 . . . . 0.0 110.208 -167.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -134.97 97.99 13.34 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -69.9 -6.5 18.82 Favored 'Trans proline' 0 C--O 1.238 0.492 0 N-CA-C 121.308 3.541 . . . . 0.0 121.308 -169.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.7 p -112.55 165.21 12.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.852 0.751 . . . . 0.0 110.407 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.21 150.81 60.94 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.38 157.17 88.05 Favored 'Cis proline' 0 C--N 1.345 0.392 0 N-CA-C 117.767 2.18 . . . . 0.0 117.767 4.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -126.03 123.17 37.85 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.7 tp -107.79 130.25 54.98 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -118.8 137.58 53.3 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 77.7 mt -136.75 130.04 45.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.34 25.6 75.32 Favored Glycine 0 C--O 1.235 0.174 0 O-C-N 122.117 -0.364 . . . . 0.0 112.467 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 79.95 5.77 89.39 Favored Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 114.481 0.552 . . . . 0.0 114.481 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -124.83 145.92 49.53 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -66.57 121.56 15.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -89.77 -48.03 7.52 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 169.85 175.86 39.16 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 118.999 -1.572 . . . . 0.0 116.236 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -93.17 -164.9 37.71 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 31.6 t -62.4 -42.0 99.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 118.01 0.905 . . . . 0.0 112.851 -173.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -68.5 -38.84 81.32 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.261 -0.899 . . . . 0.0 113.094 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.32 -44.73 94.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.41 HG21 HG13 ' A' ' 103' ' ' VAL . 58.9 m -63.11 -40.11 96.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 45.9 tp -66.4 -43.58 85.39 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.758 -0.588 . . . . 0.0 110.562 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -69.02 -32.9 72.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.709 0.766 . . . . 0.0 109.739 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.55 -35.46 79.09 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.219 -0.926 . . . . 0.0 111.749 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -67.96 -40.39 83.2 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.163 -0.961 . . . . 0.0 109.892 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.63 -20.1 64.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.8 p -106.81 -10.23 16.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 88.33 -6.95 82.96 Favored Glycine 0 C--O 1.226 -0.383 0 O-C-N 121.645 -0.659 . . . . 0.0 113.352 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -68.34 -25.0 64.88 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.687 -0.89 . . . . 0.0 113.081 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.29 -42.93 64.95 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -63.23 -38.4 91.01 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -61.39 -39.67 91.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 118.396 0.544 . . . . 0.0 112.015 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -73.7 -38.22 64.93 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.025 -0.422 . . . . 0.0 112.121 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.72 -42.94 96.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.11 -42.86 99.29 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -58.74 -47.76 83.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.97 -46.23 78.81 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.85 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 95.7 mmm -66.15 -33.15 75.13 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 121.903 -0.498 . . . . 0.0 111.647 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 77.4 m -84.05 -13.81 52.19 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.838 -0.601 . . . . 0.0 109.651 177.634 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 71.8 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 50.3 p -127.08 165.02 20.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 171.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.14 -39.57 75.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.218 0.532 . . . . 0.0 110.4 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -65.89 -32.79 74.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.441 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -73.34 -38.57 65.71 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.309 -0.869 . . . . 0.0 110.14 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 57.1 t -60.62 -47.74 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -62.66 -46.19 89.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.407 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.03 -41.1 87.15 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 17.3 p -67.05 -38.08 85.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.171 0.51 . . . . 0.0 110.808 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.7 -38.12 73.62 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.213 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -65.15 -46.67 79.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 25.8 p -65.06 -32.38 74.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.409 0.623 . . . . 0.0 111.11 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -83.79 -54.38 4.94 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 64.9 mt -89.75 -11.1 43.23 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -165.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 49.58 53.53 14.51 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 123.623 0.769 . . . . 0.0 112.379 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.58 146.39 38.91 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 116.975 -1.55 . . . . 0.0 115.048 -168.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -82.99 -31.23 8.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -143.71 139.37 29.45 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 169.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 52.5 tp -135.11 140.71 45.68 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 172.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -128.41 135.46 49.54 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 167.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 88.1 t -127.62 131.9 69.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 102.771 -3.048 . . . . 0.0 102.771 171.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 64.1 mt -124.53 122.42 63.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -76.36 120.44 21.61 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 27.5 pt -107.96 2.83 9.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 122.184 0.993 . . . . 0.0 111.279 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 88.5 p -90.15 7.52 37.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.328 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.0 22.99 53.87 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.271 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.22 10.14 78.49 Favored Glycine 0 C--N 1.325 -0.072 0 O-C-N 121.993 -0.71 . . . . 0.0 112.485 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' CYS . . . . . . . . . . . . . 47.6 t -74.71 -16.62 60.74 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.11 -0.641 . . . . 0.0 110.825 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.88 21.93 77.72 Favored Glycine 0 N--CA 1.454 -0.133 0 O-C-N 121.363 -0.836 . . . . 0.0 111.711 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 79.2 p -113.01 -17.58 12.41 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.5 m -144.15 138.44 28.15 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.194 0.907 . . . . 0.0 110.442 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -137.27 155.67 49.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -116.87 141.15 48.59 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 166.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 95.1 t -135.99 134.29 50.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.765 0.426 . . . . 0.0 111.052 -173.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -124.2 129.39 50.72 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 171.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 t -125.78 142.99 40.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.07 128.8 70.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 169.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 42.0 t -157.76 150.78 23.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 119.436 1.016 . . . . 0.0 109.235 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -75.65 -13.35 60.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.995 -0.441 . . . . 0.0 110.237 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -63.98 -22.52 66.96 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.974 -0.454 . . . . 0.0 111.094 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -79.74 -11.39 59.84 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.36 138.95 55.8 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.09 4.14 84.5 Favored Glycine 0 C--O 1.237 0.284 0 CA-C-O 121.595 0.553 . . . . 0.0 113.422 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -125.67 134.01 51.98 Favored 'General case' 0 CA--C 1.51 -0.576 0 O-C-N 122.09 -0.653 . . . . 0.0 109.706 -173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 29.9 mmt85 -77.08 158.33 30.55 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 22.0 tp -56.32 -33.54 65.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -170.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.41 -42.65 99.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.699 0.761 . . . . 0.0 110.833 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -66.5 -37.46 85.12 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.124 -0.985 . . . . 0.0 110.006 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -66.5 -40.11 89.08 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.889 -0.507 . . . . 0.0 111.637 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -62.58 -41.86 99.2 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -59.48 -37.72 78.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.476 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' MET . . . . . . . . . . . . . 59.1 mtp -63.46 -41.77 98.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.597 0.635 . . . . 0.0 111.829 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -68.72 -43.35 83.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -63.7 -36.31 83.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.75 -32.6 72.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.116 0.484 . . . . 0.0 110.224 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.66 -43.11 81.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.06 35.26 2.26 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.551 1.167 . . . . 0.0 112.433 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -58.77 -34.99 72.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 -36.09 65.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.955 0.883 . . . . 0.0 111.994 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.68 -37.24 73.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.188 0.994 . . . . 0.0 110.027 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 47.6 tpp -58.64 -26.7 64.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.772 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -71.19 -17.39 62.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.007 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -115.98 -38.93 3.54 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 45.4 pt -66.03 156.11 6.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -103.24 -11.57 17.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.958 -1.474 . . . . 0.0 114.043 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.19 152.44 20.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 119.021 0.828 . . . . 0.0 111.449 166.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.4 tp -143.44 132.23 22.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.67 94.2 3.9 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.854 0.835 . . . . 0.0 109.744 172.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -73.26 119.43 20.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -100.32 -37.89 8.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -139.81 143.4 36.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.96 55.42 1.31 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -88.05 151.17 22.94 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -160.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 70.9 p -72.57 159.91 84.16 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 162.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.25 -29.19 88.42 Favored 'Trans proline' 0 N--CA 1.473 0.269 0 C-N-CA 116.803 -1.665 . . . . 0.0 113.766 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -70.19 -30.55 67.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -76.04 -37.41 58.36 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.023 -1.048 . . . . 0.0 111.091 172.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -63.14 -42.03 99.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.084 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -127.09 86.87 57.87 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 118.333 -0.645 . . . . 0.0 112.967 -178.96 . . . . . . . . 0 0 . 1 stop_ save_